334 related articles for article (PubMed ID: 27793635)
1. The value of quantitative analysis in
Lapa P; Marques M; Costa G; Lima JP
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
3. Uptake of Radium-223 Dichloride and Early [
Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of two-phase
Seo JH; Lee SM; Yu SN; Lee JW; Lee JE
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):238-242. PubMed ID: 30665751
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using
Nakuz TS; Millinger FP; El-Rabadi K; Weber M; Pichler V; Wadsak W; Mitterhauser M; Haug A; Hacker M; Karanikas G; Pietschmann P; Agis H
Anticancer Res; 2019 Apr; 39(4):1943-1952. PubMed ID: 30952737
[TBL] [Abstract][Full Text] [Related]
6. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
8. F-18 fluoride uptake in primary breast cancer.
Sarikaya I; Sharma P; Sarikaya A
Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199
[TBL] [Abstract][Full Text] [Related]
9. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
Moragas M; Soler M; Riera E; García JR
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study of Serial
Peterson LM; O'Sullivan J; Wu QV; Novakova-Jiresova A; Jenkins I; Lee JH; Shields A; Montgomery S; Linden HM; Gralow J; Gadi VK; Muzi M; Kinahan P; Mankoff D; Specht JM
J Nucl Med; 2018 Dec; 59(12):1823-1830. PubMed ID: 29748233
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Response to Tumor Necrosis Value-α Blocker Is Suggested by
Kim K; Son SM; Goh TS; Pak K; Kim IJ; Lee JS; Kim SJ
AJR Am J Roentgenol; 2020 Jun; 214(6):1352-1358. PubMed ID: 32286869
[No Abstract] [Full Text] [Related]
13. Differences in sodium fluoride-18 uptake in the normal skeleton depending on the location and characteristics of the bone.
Nawata S; Kaneta T; Ogawa M; Ishiwata Y; Kobayashi N; Shishikura-Hino A; Yoshida K; Inaba Y; Saito T; Inoue T
Nuklearmedizin; 2017 Jun; 56(3):91-96. PubMed ID: 28488727
[TBL] [Abstract][Full Text] [Related]
14. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
Hardcastle N; Hofman MS; Lee CY; Callahan J; Selbie L; Foroudi F; Shaw M; Chander S; Lim A; Chesson B; Murphy DG; Kron T; Siva S
Radiat Oncol; 2019 Sep; 14(1):164. PubMed ID: 31488175
[TBL] [Abstract][Full Text] [Related]
15. 18F-sodium fluoride PET/CT in oncology: an atlas of SUVs.
Sabbah N; Jackson T; Mosci C; Jamali M; Minamimoto R; Quon A; Mittra ES; Iagaru A
Clin Nucl Med; 2015 Apr; 40(4):e228-31. PubMed ID: 25546225
[TBL] [Abstract][Full Text] [Related]
16. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [
Azad GK; Taylor BP; Green A; Sandri I; Swampillai A; Harries M; Kristeleit H; Mansi J; Goh V; Cook GJR
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):821-830. PubMed ID: 30506455
[TBL] [Abstract][Full Text] [Related]
17. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
[TBL] [Abstract][Full Text] [Related]
18. Observer Agreement and Accuracy of
Zacho HD; Fonager RF; Nielsen JB; Haarmark C; Hendel HW; Johansen MB; Mortensen JC; Petersen LJ
J Nucl Med; 2020 Mar; 61(3):344-349. PubMed ID: 31481577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Zhang Y; Chen Y; Huang Z; Zhang L; Wan Q; Lei L
Contrast Media Mol Imaging; 2018; 2018():8271313. PubMed ID: 30254551
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of
Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A
Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
